ADAPALENE AND BENZOYL PEROXIDE Drug Patent Profile
✉ Email this page to a colleague
When do Adapalene And Benzoyl Peroxide patents expire, and when can generic versions of Adapalene And Benzoyl Peroxide launch?
Adapalene And Benzoyl Peroxide is a drug marketed by Actavis Labs Ut Inc, Actavis Mid Atlantic, Alembic, Encube, Glenmark Pharms Ltd, Padagis Israel, Taro, and Zydus Pharms. and is included in ten NDAs.
The generic ingredient in ADAPALENE AND BENZOYL PEROXIDE is adapalene; benzoyl peroxide. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Adapalene And Benzoyl Peroxide
A generic version of ADAPALENE AND BENZOYL PEROXIDE was approved as adapalene; benzoyl peroxide by PADAGIS ISRAEL on January 23rd, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ADAPALENE AND BENZOYL PEROXIDE?
- What are the global sales for ADAPALENE AND BENZOYL PEROXIDE?
- What is Average Wholesale Price for ADAPALENE AND BENZOYL PEROXIDE?
Summary for ADAPALENE AND BENZOYL PEROXIDE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 10 |
| Clinical Trials: | 42 |
| What excipients (inactive ingredients) are in ADAPALENE AND BENZOYL PEROXIDE? | ADAPALENE AND BENZOYL PEROXIDE excipients list |
| DailyMed Link: | ADAPALENE AND BENZOYL PEROXIDE at DailyMed |
Recent Clinical Trials for ADAPALENE AND BENZOYL PEROXIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Oklahoma | Phase 3 |
| Treatment and Diagnostic Center of Private Enterprise "Asklepiy" | N/A |
| delta medical promotions ag | N/A |
Pharmacology for ADAPALENE AND BENZOYL PEROXIDE
| Drug Class | Retinoid |
US Patents and Regulatory Information for ADAPALENE AND BENZOYL PEROXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 209641-001 | Jun 22, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Padagis Israel | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 212464-001 | May 31, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Encube | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 206164-001 | May 23, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | ADAPALENE AND BENZOYL PEROXIDE | adapalene; benzoyl peroxide | GEL;TOPICAL | 206959-001 | Jan 24, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
